Stephan R Orth

Summary

Country: Germany

Publications

  1. ncbi Smoking: a risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients--absence of evidence or evidence of absence?
    Stephan R Orth
    Dialysis Center Bad Aibling, Bad Aibling, Germany
    Clin J Am Soc Nephrol 3:226-36. 2008
  2. ncbi Effect of a selective endothelin receptor A blocker on cardiovascular remodeling in uninephrectomized spontaneously hypertensive rats of the stroke-prone strain
    Stephan R Orth
    Department of Internal Medicine II, University of Regensburg, Regensburg, Germany
    Kidney Blood Press Res 30:400-7. 2007
  3. ncbi Effects of smoking on systemic and intrarenal hemodynamics: influence on renal function
    Stephan R Orth
    Dialysezentrum Schwandorf Klinikum für Innere Medizin II, University of Regensburg, Germany
    J Am Soc Nephrol 15:S58-63. 2004
  4. ncbi Traditional and nontraditional cardiovascular risk factors and estimated risk for coronary artery disease in renal transplant recipients: a single-center experience
    Miriam C Banas
    Klinik und Poliklinik fur Innere Medizin II, Nephrologie, University of Regensburg, Regensburg, Germany
    Nephron Clin Pract 119:c227-35. 2011
  5. ncbi Smoking behaviour of patients before and after renal transplantation
    Miriam C Banas
    Klinik und Poliklinik fur Innere Medizin II, University of Regensburg, D 93042 Regensburg, Germany
    Nephrol Dial Transplant 23:1442-6. 2008
  6. ncbi Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus
    Stephan R Orth
    , University of Regensburg, Regensburg, Germany
    Nephrol Dial Transplant 20:2414-9. 2005
  7. ncbi Blood pressure-independent effect of long-term treatment with the soluble heme-independent guanylyl cyclase activator HMR1766 on progression in a model of noninflammatory chronic renal damage
    Kerstin Benz
    Department of Pediatrics, University of Erlangen, Erlangen, Germany
    Kidney Blood Press Res 30:224-33. 2007
  8. ncbi Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors
    Hiroaki Ogata
    Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
    J Am Soc Nephrol 14:959-67. 2003
  9. ncbi Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant vasculopathy in different aorta allotransplantation rat models
    Stephan R Orth
    Division of Nephrology and Hypertension, University Hospital Berne Inselspital, Berne, Switzerland
    Nephrol Dial Transplant 18:62-9. 2003
  10. ncbi Monocyte chemoattractant protein-1 (MCP-1) in the kidney: does it more than simply attract monocytes?
    Christiane Viedt
    Nephrol Dial Transplant 17:2043-7. 2002

Collaborators

Detail Information

Publications16

  1. ncbi Smoking: a risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients--absence of evidence or evidence of absence?
    Stephan R Orth
    Dialysis Center Bad Aibling, Bad Aibling, Germany
    Clin J Am Soc Nephrol 3:226-36. 2008
    ..The conclusion is that smoking is an important renal risk factor, and nephrologists have to invest more efforts to motivate patients to stop smoking...
  2. ncbi Effect of a selective endothelin receptor A blocker on cardiovascular remodeling in uninephrectomized spontaneously hypertensive rats of the stroke-prone strain
    Stephan R Orth
    Department of Internal Medicine II, University of Regensburg, Regensburg, Germany
    Kidney Blood Press Res 30:400-7. 2007
    ....
  3. ncbi Effects of smoking on systemic and intrarenal hemodynamics: influence on renal function
    Stephan R Orth
    Dialysezentrum Schwandorf Klinikum für Innere Medizin II, University of Regensburg, Germany
    J Am Soc Nephrol 15:S58-63. 2004
    ..g., endothelial cell dysfunction). Renal failure per se leads to an increased cardiovascular risk. The latter is further aggravated by smoking. Particularly, survival of smokers with diabetes on hemodialysis is abysmal...
  4. ncbi Traditional and nontraditional cardiovascular risk factors and estimated risk for coronary artery disease in renal transplant recipients: a single-center experience
    Miriam C Banas
    Klinik und Poliklinik fur Innere Medizin II, Nephrologie, University of Regensburg, Regensburg, Germany
    Nephron Clin Pract 119:c227-35. 2011
    ....
  5. ncbi Smoking behaviour of patients before and after renal transplantation
    Miriam C Banas
    Klinik und Poliklinik fur Innere Medizin II, University of Regensburg, D 93042 Regensburg, Germany
    Nephrol Dial Transplant 23:1442-6. 2008
    ..To date, only limited information about changes in cigarette-smoking habits before and after renal transplantation is available...
  6. ncbi Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus
    Stephan R Orth
    , University of Regensburg, Regensburg, Germany
    Nephrol Dial Transplant 20:2414-9. 2005
    ..The latter finding suggests a mechanism independent of glomerular damage...
  7. ncbi Blood pressure-independent effect of long-term treatment with the soluble heme-independent guanylyl cyclase activator HMR1766 on progression in a model of noninflammatory chronic renal damage
    Kerstin Benz
    Department of Pediatrics, University of Erlangen, Erlangen, Germany
    Kidney Blood Press Res 30:224-33. 2007
    ..6 +/- 9). The results document beneficial BP-independent HMR1766 effects on kidney structure and urinary albumin excretion in a noninflammatory model of renal failure and may argue for a novel therapeutic principle...
  8. ncbi Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors
    Hiroaki Ogata
    Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
    J Am Soc Nephrol 14:959-67. 2003
    ..Furthermore, it interferes with the development of cardiovascular risk factors and cardiac remodeling...
  9. ncbi Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant vasculopathy in different aorta allotransplantation rat models
    Stephan R Orth
    Division of Nephrology and Hypertension, University Hospital Berne Inselspital, Berne, Switzerland
    Nephrol Dial Transplant 18:62-9. 2003
    ..Untreated sham-operated and isografted WKY and SHR served as controls. Allotransplanted animals treated with the angiotensin-converting enzyme (ACE) inhibitor trandolapril served as positive treatment controls...
  10. ncbi Monocyte chemoattractant protein-1 (MCP-1) in the kidney: does it more than simply attract monocytes?
    Christiane Viedt
    Nephrol Dial Transplant 17:2043-7. 2002
  11. ncbi The renal risks of smoking: an update
    Stephan R Orth
    Division of Nephrology and Hypertension, Inselspital, University of Berne, Berne, Switzerland
    Curr Opin Nephrol Hypertens 11:483-8. 2002
    ..For all the above reasons cessation of smoking should be recommended to renal patients - a recommendation which is infrequently given and even less frequently followed...
  12. ncbi Smoking and the kidney
    Stephan R Orth
    Division of Nephrology and Hypertension, University Hospital Berne (Inselspital, Berne, Switzerland
    J Am Soc Nephrol 13:1663-72. 2002
  13. ncbi Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant nephropathy in a 'Fisher-to-Lewis' rat model
    Judith Adams
    Department of Urology, Ruperto Carola University, Heidelberg, Germany
    Nephrol Dial Transplant 17:780-7. 2002
    ..This finding is consistent with the notion that ET(A)-receptor mediated events play a partly BP-independent role in the genesis of CTN. Combination therapy exerts no additive nephroprotection...
  14. ncbi Smoking and dialysis: a dreadful scenario for the cardiovascular system?
    Stephan R Orth
    Kidney Int 63:1580-1. 2003
  15. ncbi Adverse effect of smoking on renal function in the general population: are men at higher risk?
    Stephan R Orth
    Am J Kidney Dis 40:864-6. 2002
  16. ncbi Cigarette smoke condensate aggravates renal injury in the renal ablation model
    Giulio Odoni
    Department of Internal Medicine, Ruperto Carola University, Heidelberg, Germany
    Kidney Int 61:2090-8. 2002
    ..Renal injury induced by cigarette smoke condensate in this model is reversed by renal denervation. We conclude that cigarette smoke-induced renal damage is due, at least in part, to activation of the sympathetic nerve system...